Business
Techniclone Corp. completed the acquisition of Peregrine Pharmaceuticals Inc. for 5.08 million shares of common stock.
June 5, 1997
Pharmaceutical company Techniclone Corp. said Thursday it has agreed to acquire Peregrine Pharmaceuticals of Princeton, N.J., for stock.
Jan. 19, 1997
Biopharmaceutical company Peregrine Pharmaceuticals Inc. in Tustin said Friday that it has agreed with Schering AG to transfer management of the development of its lymphoma drug Oncolym from the German company to Peregrine.
June 9, 2001
Peregrine plummets after unreliable lung cancer trial
Sept. 25, 2012
Tustin biopharmaceutical company Techniclone Corp. announced Monday that it had changed its name to Peregrine Pharmaceuticals Inc., formerly the name of one of its subsidiaries.
Nov. 7, 2000
Peregrine Pharmaceuticals Inc., a Tustin biopharmaceutical company, said Friday that John Bonfiglio, its chief executive and president, has taken a leave of absence for an unspecified length of time.
Feb. 10, 2001
Techniclone Corp., the Tustin developer of tumor treatments, is already trumpeting research advances by a company it’s about to acquire.
Jan. 28, 1997
Peregrine Pharmaceuticals Inc. in Tustin said its drug candidate Cortara showed favorable results by slowing the growth of brain tumors in a clinical trial.
Jan. 10, 2001
Three Orange County companies are among the 37 California drug firms working on treatments for cancer, the nation’s second-leading killer, according to a biannual survey by Pharmaceutical Research and Manufacturers of America, a Washington, D.C.
April 10, 2001
Technology and the Internet
A state judge dismissed San Diego Padres owner John Moores and other former directors of Peregrine Systems Inc. from a lawsuit that alleges insider trading and breach of fiduciary duty at the software company.
April 2, 2005